Psoriatic exacerbation associated with insulin therapy

Diabetes Care

Volumn 31, Issue 5, 2008, Pages

  Moore, Allan F ^a   Soper, Tiffany ^a   Jones, Natalie ^b   Grevelink, Joop ^b   Abourizk, Nicolas ^a,c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b Boston Dermatology and Laser Center   (United States)

^c NEWTON WELLESLEY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ATORVASTATIN; GLIBENCLAMIDE; HEMOGLOBIN A1C; HYDROCORTISONE; INSULIN GLARGINE; ISOPHANE INSULIN; ISOSORBIDE MONONITRATE; METFORMIN; TIMOLOL; VALSARTAN; ANTIDIABETIC AGENT; DRUG DERIVATIVE; GLARGINE; INSULIN;

AGED; ANAMNESIS; CASE REPORT; CLINICAL FEATURE; DISEASE EXACERBATION; HUMAN; INSULIN BLOOD LEVEL; INSULIN TREATMENT; INSULINOMA; LETTER; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PSORIASIS; DISEASE COURSE; MIDDLE AGED; PATHOPHYSIOLOGY;

AGED; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; METFORMIN; MIDDLE AGED; PSORIASIS;

EID: 48649096253     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc08-0230     Document Type: Letter

References (5)

1. Field S, Kelly G, Tobin AM, Barragry JM, Conlon KC, Kirby B: Severe deterioration of psoriasis due to an insulinoma. Clin Exp Dermatol 33:145-147, 2008
2. Hyde C, Hollier B, Anderson A, Harkin D, Upton Z: Insulin-like growth factors (IGF) and IGF-binding proteins bound to vitronectin enhance keratinocyte protein synthesis and migration. J Invest Dermatol 122:1198-1206, 2004
3. Pirgon O, Atabek ME, Sert A: Psoriasis following growth hormone therapy in a child. Ann Pharmacother 41:157-160, 2007
4. Koca R, Altinyazar HC, Yenidunya S, Tekin NS: Psoriasiform drug eruption associated with metformin hydrochloride: a case report. Dermatology Online Journal 9:11, 2003
5. Goh CL: Psoriasiform drug eruption due to glibenclamide. Australas J Dermatol 28: 30-32, 1987